Hematology Oncology Services of Arkansas

Little Rock, Arkansas 72205

0 studies enrolling now · 12 studies all time

What they study most

Breast Cancer, Carcinoid Syndrome, Carcinoid Tumor, First or Second Line HER2-negative Breast Cancer, Malignant Carcinoid Syndrome, Metastatic Disease Without Bone Metastasis, Multiple Myeloma, Neuroendocrine Carcinoma, Ovarian Neoplasms, Renal Cell Carcinoma, Sickle Cell Disease

Studies at this site

• Rheumatological Evaluation of Anastrozole and Letrozole as Adjuvant Treatment in Post-menopausal Women With Breast Cancer — Completed
• Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer — Completed
• A 3-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients — Completed
• Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome Not Managed by Stable-Dose Octreotide Therapy — Completed
• An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry) — Completed
• Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects — Completed
• Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor — Completed
• Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients — Completed
• Velcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and Prednisone — Completed
• Phase 3 Randomized Study of Telcyta + Doxorubicin Versus Doxorubicin in Platinum Refractory or Resistant Ovarian Cancer — Stopped early
• Extension Study of the Safety and Efficacy of Atiprimod Treatment in Neuroendocrine Carcinoma — Completed
• Safety and Efficacy of Atiprimod Treatment for Patients With Low to Intermediate Grade Neuroendocrine Carcinoma — Completed